Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin light chain pseudogene 16 (FTLP16) is a pseudogene located in the human genome, recognized in the official gene nomenclature as HGNC:37966. Unlike protein-coding genes, pseudogenes do not produce functional proteins, and FTLP16 does not have demonstrated biological activity, therapeutic relevance, or disease association. FTLP16 is part of a large family of ferritin light chain-related sequences, many of which are pseudogenes. In contrast, the functional ferritin light chain gene (FTL) encodes the light subunit of the ferritin protein, a major iron storage protein critical for iron homeostasis and neurological health. FTLP16 itself holds no known clinical or pharmacological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin light chain pseudogene 16 (FTLP16).